Resiquimod, a topical drug for viral skin lesions and skin cancer.
Beteiligte Einrichtungen
Abstract
Resiquimod is an immune response modifier which stimulates cells through a toll-like receptors (TLR) 7 and 8 dependent pathway resulting in activation of immune responses that are effective against viral and tumor lesions.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 1 |
| ISSN | 1354-3784 |
| Status | Veröffentlicht - 2013 |
| pubmed | 23205468 |
|---|
